The store will not work correctly when cookies are disabled.
N'-(1-p-tolylethylidene)benzohydrazide
ID: ALA2238553
Cas Number: 22454-49-5
PubChem CID: 5409960
Max Phase: Preclinical
Molecular Formula: C16H16N2O
Molecular Weight: 252.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C/C(=N\NC(=O)c1ccccc1)c1ccc(C)cc1
Standard InChI: InChI=1S/C16H16N2O/c1-12-8-10-14(11-9-12)13(2)17-18-16(19)15-6-4-3-5-7-15/h3-11H,1-2H3,(H,18,19)/b17-13+
Standard InChI Key: AWWXRFPQSOVNTR-GHRIWEEISA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
19.5947 -18.9646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5935 -19.7841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3016 -20.1931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0112 -19.7836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0084 -18.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2998 -18.5557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8855 -20.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7146 -18.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4238 -18.9556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7115 -17.7325 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4176 -17.3213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.4146 -16.5041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1207 -16.0928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7053 -16.0982 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.8289 -16.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5346 -16.0907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5319 -15.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8177 -14.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1149 -15.2798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
5 8 1 0
8 9 1 0
8 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
13 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 13 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 252.32 | Molecular Weight (Monoisotopic): 252.1263 | AlogP: 3.15 | #Rotatable Bonds: 3 |
Polar Surface Area: 41.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.62 | CX Basic pKa: 1.81 | CX LogP: 3.32 | CX LogD: 3.32 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.66 | Np Likeness Score: -1.49 |
References
1. Misra S, Pandeya KB, Tiwari AK, Ali AZ, Saradamani T, Agawane SB, Madhusudana K. (2011) Antihyperglycemic, -glucosidase inhibitory and DPPH free radical scavenging activity of 5-bromosalicylaldehyde and schiff bases, 20 (9): [10.1007/s00044-010-9377-3] |